Filing Flows › Medicinova (MNOV) › Q4 2025
Medicinova (MNOV) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 10, 2026
Medicinova (MNOV) reported revenue of $152K for the fourth quarter 2025 (Q4 2025) and +23% from the quarter before.
Medicinova, Q4 2025: revenue $152K, net loss $2.8M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $152K | +23% | — |
| Operating profit | −$3.1M | — | — |
| Net earnings | −$2.8M | — | — |
| Operating cash flow | −$2.0M | — | — |
What changed
Revenue was $152K in Q4 2025, up 23% from the previous quarter.
Operating costs exceeded revenue by $3.1M, an operating margin of -2038.0%. The quarter ended with a net loss of $2.8M, narrower than the previous quarter's $3.1M loss.
Operating cash flow was −$2.0M. Non-cash charges added back $5K of depreciation and amortization and $181K of share-based compensation. Working capital and other items added $600K.
Questions
What was Medicinova's revenue in the fourth quarter 2025?
Medicinova (MNOV) reported revenue of $152K for the fourth quarter 2025 (Q4 2025) and +23% from the quarter before.
Source: Medicinova 10-K on SEC EDGAR.